Released: Tuesday 13th March 2012

Life Sciences Industry Leader, Dr John Brown, Joins BioCity Nottingham Board

Dr John Brown CBE FRSE has been appointed as a non-executive Director to the Board of BioCity Nottingham Ltd, which runs one of Europe’s largest bioscience business incubators. His arrival comes just two months after the launch of BioCity Scotland, and marks another step-change in the growth ambitions of the company.

Dr Brown brings extensive experience in the life sciences sector; he is currently Chairman of CXR Biosciences Ltd, and a non-executive Director of Vectura Group PLC. Dr Brown also plays a major role in public sector life sciences organisations. He chairs the Roslin Foundation, co-chairs the Life Sciences Industry Advisory Board for the Scottish Government and is a non-executive Director of the Technology Strategy Board. Dr Brown was appointed CBE for services to Science in June 2011.

Dr Brown has served as a Director of several private and public life science companies. Most recently he was Chairman of BTG plc and Axis-Shield plc. Early in his career Dr Brown spent five years with Glaxo Group Research where he published extensively on neuropeptide antagonists. Subsequently he worked in equity research, and in advising biotechnology, pharmaceutical companies, and investment banks. In 1995 he joined Acambis PLC, a leading producer of vaccines to treat and prevent infectious diseases, and held the post of chief executive from 1997 to 2003. Under his leadership he took the company through public flotation to become one of the UK’s most successful, and profitable, biotechnology businesses.
Commenting on his appointment to the BioCity Nottingham board Dr Brown said, “I’m delighted to be working with the BioCity team. Emulating the successful BioCity model at BioCity Scotland is just the first step for a company with exceptional growth potential.’’

Dr Louis Nisbet, BioCity Chairman said, “We are delighted to welcome John to the Board of BioCity Nottingham Ltd. It will be immensely valuable to draw on his extensive experience as our organisation continues to grow as a leading provider of incubation facilities and services to start-up and fast growing life sciences companies. Few individuals have the depth and breadth of experience that he will bring to BioCity and to the companies we support.”

ENDS
Photo: Dr John Brown CBE FRSE
Media contact:
Louise Third – BioCity public relations
Tel: 0115 912 4350 / 07773 288342
louise@integracommunications.co.uk

NOTES
www.biocity.co.uk
About BioCity Nottingham Ltd
BioCity Nottingham Ltd has developed and operates one of the largest bioscience incubators in Europe. Home to around 70 early-stage businesses it is a hot-bed of entrepreneurial activity in the sector. As well as providing very flexible laboratory and office facilities, BioCity Nottingham is able to provide on-site a whole range of non-core but vital services to businesses which would otherwise be costly and inefficient for them to develop in-house. This ensures that companies with BioCity Nottingham have maximum opportunity for success and investors see the most efficient use of their funds. The Board currently comprises; Dr Louis J Nisbet (Chairman); Dr Glenn Crocker CEO, BioCity; Professor Neil T Gorman, Vice Chancellor, Nottingham Trent University; Professor Chris Rudd, Pro Vice Chancellor, The University of Nottingham; Lucy P Marcus, Founder and CEO of Marcus Venture Consulting; Stefan Ogrodzinski, CEO, Biostatus Ltd; and Ian JS Webster, Independent Consultant. For more information go to www.biocity.co.uk